While Mounjaro and Ozempic are FDA-approved for type 2 diabetes, Zepbound is approved for weight loss only
Serious but Rare Risks GLP-1 medications can aggravate or trigger severe pancreatic inflammation in some patients. Both oral and injectable GLP-1 medications may cause gallbladder disease, and in rare cases involving patients with relevant risk factors, there have been associations with thyroid changes observed in animal studies. A serious allergic reaction is possible but uncommon
The 2.5 mg measurement in Zepbound refers to the total milligrams of tirzepatide contained in a single pre-filled injection pen
However, if the reduced catalytic activity in the variant enzyme is overcome in riboflavin replete subjects due to increased cellular FAD content, this might explain why folate status was no longer important in predicting tHcy in subjects with the variant enzyme that were riboflavin replete
It helps protect cells from oxidative stress and is commonly included in routines focused on supporting brighter-looking skin, overall skin radiance, and an even-looking complexion